Dysregulation of glutamate carboxypeptidase II in psychiatric disease
- 29 February 2008
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 99 (1-3), 324-332
- https://doi.org/10.1016/j.schres.2007.11.013
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Expression of glutamate carboxypeptidase II in human brainNeuroscience, 2007
- Glutamate carboxypeptidase II levels in rodent brain using [125I]DCIT quantitative autoradiographyNeuroscience Letters, 2005
- Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depressionProceedings of the National Academy of Sciences, 2005
- The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophreniaTrends in Pharmacological Sciences, 2005
- N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem studyBiological Psychiatry, 2003
- Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase).1998
- Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imagingAmerican Journal of Psychiatry, 1996
- Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophreniaPsychological Medicine, 1995
- Hydrolysis of the Brain Dipeptide N‐Acetyl‐l‐Aspartyl‐l‐Glutamate: Subcellular and Regional Distribution, Ontogeny, and the Effect of Lesions on N‐Acetylated‐α‐Linked Acidic Dipeptidase ActivityJournal of Neurochemistry, 1988
- A study of possible excitatory effects of N-acetylaspartylglutamate in different in vivo and in vitro brain preparationsBrain Research, 1984